Wordt geladen...
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Adoptive cell therapy using chimeric antigen receptor (CAR)-engineered T cells has emerged as a very promising approach to combating cancer. Despite its ability to eliminate tumors shown in some clinical trials, CAR-T cell therapy involves some significant safety challenges, such as cytokine release...
Bewaard in:
| Gepubliceerd in: | J Hematol Oncol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5210295/ https://ncbi.nlm.nih.gov/pubmed/28049484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-016-0379-6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|